9.83
price up icon1.87%   0.18
after-market After Hours: 9.75 -0.08 -0.81%
loading
Rezolute Inc stock is traded at $9.83, with a volume of 1.34M. It is up +1.87% in the last 24 hours and up +10.95% over the past month. Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
See More
Previous Close:
$9.65
Open:
$9.45
24h Volume:
1.34M
Relative Volume:
0.95
Market Cap:
$911.51M
Revenue:
-
Net Income/Loss:
$-69.31M
P/E Ratio:
-7.7402
EPS:
-1.27
Net Cash Flow:
$-62.80M
1W Performance:
-0.41%
1M Performance:
+10.95%
6M Performance:
+145.14%
1Y Performance:
+102.26%
1-Day Range:
Value
$9.32
$9.93
1-Week Range:
Value
$9.32
$10.64
52-Week Range:
Value
$2.215
$11.46

Rezolute Inc Stock (RZLT) Company Profile

Name
Name
Rezolute Inc
Name
Phone
650-206-4507
Name
Address
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Name
Employee
71
Name
Twitter
Name
Next Earnings Date
2025-09-17
Name
Latest SEC Filings
Name
RZLT's Discussions on Twitter

Compare RZLT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
RZLT
Rezolute Inc
9.83 894.82M 0 -69.31M -62.80M -1.27
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.76 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
755.90 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
436.38 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
918.92 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
198.76 42.58B 447.02M -1.18B -906.14M -6.1812

Rezolute Inc Stock (RZLT) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-05-24 Initiated Wedbush Outperform
Aug-27-24 Initiated Guggenheim Buy
Jul-17-24 Initiated BTIG Research Buy
Jun-04-24 Initiated Craig Hallum Buy
Apr-09-24 Initiated Maxim Group Buy
Aug-02-22 Resumed Canaccord Genuity Buy
Jun-15-22 Initiated Cantor Fitzgerald Overweight
Sep-08-21 Initiated ROTH Capital Buy
May-27-21 Initiated Oppenheimer Outperform
May-25-21 Initiated H.C. Wainwright Buy
View All

Rezolute Inc Stock (RZLT) Latest News

pulisher
05:25 AM

Rezolute shareholders approve director slate and equity plan amendment By Investing.com - Investing.com Australia

05:25 AM
pulisher
05:19 AM

Rezolute Approves Key Proposals at Annual Meeting - TipRanks

05:19 AM
pulisher
05:17 AM

Rezolute shareholders approve director slate and equity plan amendment - Investing.com

05:17 AM
pulisher
07:34 AM

What is the fair value of Rezolute Inc. stock nowEarnings Risk Report & Daily Growth Stock Tips - newser.com

07:34 AM
pulisher
05:27 AM

Will Rezolute Inc. (6HV1) stock outperform energy sector in 20252025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com

05:27 AM
pulisher
Nov 20, 2025

BTIG Reiterates Rezolute (RZLT) Buy Recommendation - Nasdaq

Nov 20, 2025
pulisher
Nov 20, 2025

RZLT: BTIG Reiterates Buy Rating with $17 Price Target | RZLT St - GuruFocus

Nov 20, 2025
pulisher
Nov 20, 2025

Why Rezolute Inc. (6HV1) stock could rally strongly - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Rezolute Inc. (6HV1) stock announce special dividendJuly 2025 Sector Moves & Short-Term High Return Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Rezolute Inc. (6HV1) stock ideal for retirement investors2025 Performance Recap & Advanced Technical Analysis Signals - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Applying Wyckoff theory to Rezolute Inc. stockJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Rezolute Inc. bounce back from current supportJuly 2025 Momentum & Free High Return Stock Watch Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Rezolute Inc. (6HV1) stock sustain breakout momentumQuarterly Trade Report & Fast Moving Stock Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Rezolute Inc. stock remain a Wall Street favorite2025 Earnings Surprises & Long-Term Investment Growth Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Rezolute Inc. (6HV1) stock deliver double digit returns2025 Bull vs Bear & High Return Trade Opportunity Guides - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

What high frequency data says about Rezolute Inc.Bear Alert & Verified Swing Trading Watchlists - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Taking the lead: Rezolute Inc (RZLT) - Setenews

Nov 18, 2025
pulisher
Nov 16, 2025

Will Rezolute Inc. stock split again soonJuly 2025 WrapUp & Free Daily Entry Point Trade Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Will Rezolute Inc. stock benefit from infrastructure spending2025 Trade Ideas & Safe Entry Momentum Stock Tips - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

How Rezolute Inc. (6HV1) stock stacks up against competitors2025 Macro Impact & Weekly Momentum Stock Picks - newser.com

Nov 16, 2025

Rezolute Inc Stock (RZLT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
Cap:     |  Volume (24h):